nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—ABCB1—lung cancer	0.0928	1	CbGaD
Quetiapine—CYP3A5—Gefitinib—lung cancer	0.0239	0.0483	CbGbCtD
Quetiapine—CYP3A5—Teniposide—lung cancer	0.0231	0.0468	CbGbCtD
Quetiapine—CYP2C19—Gefitinib—lung cancer	0.0192	0.0389	CbGbCtD
Quetiapine—CYP2C19—Teniposide—lung cancer	0.0187	0.0377	CbGbCtD
Quetiapine—CYP3A7—Paclitaxel—lung cancer	0.0172	0.0348	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.0172	0.0348	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.017	0.0344	CbGbCtD
Quetiapine—CYP3A7—Irinotecan—lung cancer	0.017	0.0344	CbGbCtD
Quetiapine—ABCB1—Topotecan—lung cancer	0.017	0.0343	CbGbCtD
Quetiapine—ABCB1—Gefitinib—lung cancer	0.0155	0.0314	CbGbCtD
Quetiapine—CYP2D6—Gefitinib—lung cancer	0.0146	0.0296	CbGbCtD
Quetiapine—CYP3A5—Crizotinib—lung cancer	0.0146	0.0296	CbGbCtD
Quetiapine—CYP3A5—Erlotinib—lung cancer	0.0141	0.0285	CbGbCtD
Quetiapine—CYP3A5—Paclitaxel—lung cancer	0.0129	0.0261	CbGbCtD
Quetiapine—CYP3A5—Irinotecan—lung cancer	0.0127	0.0258	CbGbCtD
Quetiapine—CYP3A7—Docetaxel—lung cancer	0.0124	0.0252	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.0124	0.0252	CbGbCtD
Quetiapine—ABCB1—Vinorelbine—lung cancer	0.012	0.0242	CbGbCtD
Quetiapine—CYP2D6—Vinorelbine—lung cancer	0.0113	0.0228	CbGbCtD
Quetiapine—CYP3A5—Etoposide—lung cancer	0.0102	0.0206	CbGbCtD
Quetiapine—CYP3A4—Topotecan—lung cancer	0.0102	0.0206	CbGbCtD
Quetiapine—ABCB1—Crizotinib—lung cancer	0.00952	0.0193	CbGbCtD
Quetiapine—CYP3A5—Docetaxel—lung cancer	0.00933	0.0189	CbGbCtD
Quetiapine—CYP3A4—Gefitinib—lung cancer	0.0093	0.0188	CbGbCtD
Quetiapine—ABCB1—Gemcitabine—lung cancer	0.0093	0.0188	CbGbCtD
Quetiapine—ABCB1—Erlotinib—lung cancer	0.00918	0.0186	CbGbCtD
Quetiapine—CYP3A4—Teniposide—lung cancer	0.00902	0.0182	CbGbCtD
Quetiapine—CYP2D6—Erlotinib—lung cancer	0.00865	0.0175	CbGbCtD
Quetiapine—ABCB1—Paclitaxel—lung cancer	0.0084	0.017	CbGbCtD
Quetiapine—ABCB1—Irinotecan—lung cancer	0.00829	0.0168	CbGbCtD
Quetiapine—ABCB1—Vinblastine—lung cancer	0.00737	0.0149	CbGbCtD
Quetiapine—CYP3A4—Vinorelbine—lung cancer	0.00717	0.0145	CbGbCtD
Quetiapine—CYP2D6—Vinblastine—lung cancer	0.00694	0.014	CbGbCtD
Quetiapine—ABCB1—Cisplatin—lung cancer	0.00676	0.0137	CbGbCtD
Quetiapine—ABCB1—Etoposide—lung cancer	0.00664	0.0134	CbGbCtD
Quetiapine—ABCB1—Docetaxel—lung cancer	0.00608	0.0123	CbGbCtD
Quetiapine—HTR2A—phrenic nerve—lung cancer	0.00603	0.187	CbGeAlD
Quetiapine—CYP3A4—Crizotinib—lung cancer	0.0057	0.0115	CbGbCtD
Quetiapine—CYP3A4—Erlotinib—lung cancer	0.0055	0.0111	CbGbCtD
Quetiapine—CYP3A4—Paclitaxel—lung cancer	0.00503	0.0102	CbGbCtD
Quetiapine—CYP3A4—Irinotecan—lung cancer	0.00497	0.01	CbGbCtD
Quetiapine—ABCB1—Doxorubicin—lung cancer	0.00453	0.00916	CbGbCtD
Quetiapine—CYP3A4—Vinblastine—lung cancer	0.00442	0.00893	CbGbCtD
Quetiapine—ABCB1—Methotrexate—lung cancer	0.00439	0.00887	CbGbCtD
Quetiapine—CYP2D6—Doxorubicin—lung cancer	0.00427	0.00863	CbGbCtD
Quetiapine—CYP3A4—Etoposide—lung cancer	0.00398	0.00805	CbGbCtD
Quetiapine—CYP3A4—Docetaxel—lung cancer	0.00364	0.00736	CbGbCtD
Quetiapine—HTR7—pulmonary artery—lung cancer	0.00351	0.109	CbGeAlD
Quetiapine—CYP3A4—Doxorubicin—lung cancer	0.00271	0.00549	CbGbCtD
Quetiapine—HTR2A—pulmonary artery—lung cancer	0.00219	0.0677	CbGeAlD
Quetiapine—H1F0—mammary gland—lung cancer	0.00143	0.0444	CbGeAlD
Quetiapine—H1F0—respiratory system—lung cancer	0.000956	0.0296	CbGeAlD
Quetiapine—CHRM5—epithelium—lung cancer	0.000927	0.0287	CbGeAlD
Quetiapine—HTR3A—respiratory system—lung cancer	0.000912	0.0282	CbGeAlD
Quetiapine—ADRA1D—epithelium—lung cancer	0.000828	0.0256	CbGeAlD
Quetiapine—H1F0—bronchus—lung cancer	0.000787	0.0244	CbGeAlD
Quetiapine—H1F0—trachea—lung cancer	0.000707	0.0219	CbGeAlD
Quetiapine—H1F0—cardiac atrium—lung cancer	0.000664	0.0206	CbGeAlD
Quetiapine—HTR7—respiratory system—lung cancer	0.00059	0.0183	CbGeAlD
Quetiapine—H1F0—bone marrow—lung cancer	0.00056	0.0174	CbGeAlD
Quetiapine—DRD2—respiratory system—lung cancer	0.000558	0.0173	CbGeAlD
Quetiapine—CHRM1—trachea—lung cancer	0.000512	0.0159	CbGeAlD
Quetiapine—H1F0—lung—lung cancer	0.000508	0.0157	CbGeAlD
Quetiapine—HTR7—epithelium—lung cancer	0.000493	0.0153	CbGeAlD
Quetiapine—HTR3A—lung—lung cancer	0.000484	0.015	CbGeAlD
Quetiapine—ADRA1A—epithelium—lung cancer	0.000476	0.0147	CbGeAlD
Quetiapine—CYP3A5—respiratory system—lung cancer	0.000454	0.0141	CbGeAlD
Quetiapine—ADRA2C—bronchus—lung cancer	0.000446	0.0138	CbGeAlD
Quetiapine—HRH1—respiratory system—lung cancer	0.000441	0.0136	CbGeAlD
Quetiapine—HTR7—trachea—lung cancer	0.000436	0.0135	CbGeAlD
Quetiapine—ADRA2C—trachea—lung cancer	0.000401	0.0124	CbGeAlD
Quetiapine—ADRA2C—cardiac atrium—lung cancer	0.000376	0.0117	CbGeAlD
Quetiapine—HRH1—epithelium—lung cancer	0.000368	0.0114	CbGeAlD
Quetiapine—HTR2A—respiratory system—lung cancer	0.000368	0.0114	CbGeAlD
Quetiapine—CHRM1—lung—lung cancer	0.000368	0.0114	CbGeAlD
Quetiapine—ADRA2A—bronchus—lung cancer	0.000356	0.011	CbGeAlD
Quetiapine—H1F0—lymph node—lung cancer	0.000347	0.0108	CbGeAlD
Quetiapine—HRH1—trachea—lung cancer	0.000326	0.0101	CbGeAlD
Quetiapine—ADRA2A—trachea—lung cancer	0.00032	0.0099	CbGeAlD
Quetiapine—HTR7—lung—lung cancer	0.000313	0.0097	CbGeAlD
Quetiapine—HTR2A—epithelium—lung cancer	0.000308	0.00952	CbGeAlD
Quetiapine—ADRA2A—cardiac atrium—lung cancer	0.0003	0.0093	CbGeAlD
Quetiapine—DRD2—lung—lung cancer	0.000296	0.00917	CbGeAlD
Quetiapine—ADRA2C—lung—lung cancer	0.000288	0.00892	CbGeAlD
Quetiapine—HTR2A—trachea—lung cancer	0.000272	0.00842	CbGeAlD
Quetiapine—ABCB1—respiratory system—lung cancer	0.000241	0.00747	CbGeAlD
Quetiapine—CYP3A5—lung—lung cancer	0.000241	0.00746	CbGeAlD
Quetiapine—HRH1—lung—lung cancer	0.000234	0.00724	CbGeAlD
Quetiapine—ADRA2A—lung—lung cancer	0.00023	0.00712	CbGeAlD
Quetiapine—ABCB1—epithelium—lung cancer	0.000202	0.00624	CbGeAlD
Quetiapine—ADRA2C—lymph node—lung cancer	0.000197	0.0061	CbGeAlD
Quetiapine—Flupentixol—ABCB1—lung cancer	0.000196	0.12	CrCbGaD
Quetiapine—HTR2A—lung—lung cancer	0.000195	0.00605	CbGeAlD
Quetiapine—ABCB1—trachea—lung cancer	0.000178	0.00552	CbGeAlD
Quetiapine—HRH1—lymph node—lung cancer	0.00016	0.00495	CbGeAlD
Quetiapine—ADRA2A—lymph node—lung cancer	0.000157	0.00487	CbGeAlD
Quetiapine—Fluphenazine—CYP2E1—lung cancer	0.000157	0.0957	CrCbGaD
Quetiapine—Clozapine—CYP2A6—lung cancer	0.000147	0.0899	CrCbGaD
Quetiapine—ABCB1—bone marrow—lung cancer	0.000141	0.00438	CbGeAlD
Quetiapine—ABCB1—lung—lung cancer	0.000128	0.00397	CbGeAlD
Quetiapine—Olanzapine—ALB—lung cancer	0.00011	0.0672	CrCbGaD
Quetiapine—Nefazodone—ABCB1—lung cancer	0.00011	0.067	CrCbGaD
Quetiapine—Olanzapine—ABCB1—lung cancer	0.000105	0.0641	CrCbGaD
Quetiapine—Clozapine—CYP2E1—lung cancer	0.000105	0.0639	CrCbGaD
Quetiapine—Clozapine—CYP1A1—lung cancer	0.000103	0.063	CrCbGaD
Quetiapine—Trazodone—ABCB1—lung cancer	0.000101	0.062	CrCbGaD
Quetiapine—Thioproperazine—ALB—lung cancer	0.000101	0.0619	CrCbGaD
Quetiapine—Thiothixene—ALB—lung cancer	9.97e-05	0.0609	CrCbGaD
Quetiapine—Pipotiazine—ALB—lung cancer	9.97e-05	0.0609	CrCbGaD
Quetiapine—ABCB1—lymph node—lung cancer	8.76e-05	0.00271	CbGeAlD
Quetiapine—Fluphenazine—ABCB1—lung cancer	8.22e-05	0.0502	CrCbGaD
Quetiapine—Trifluoperazine—ABCB1—lung cancer	6.57e-05	0.0401	CrCbGaD
Quetiapine—Asthenia—Gemcitabine—lung cancer	6.3e-05	0.000259	CcSEcCtD
Quetiapine—Pain—Paclitaxel—lung cancer	6.29e-05	0.000259	CcSEcCtD
Quetiapine—Constipation—Paclitaxel—lung cancer	6.29e-05	0.000259	CcSEcCtD
Quetiapine—Confusional state—Docetaxel—lung cancer	6.28e-05	0.000259	CcSEcCtD
Quetiapine—Pharyngitis—Methotrexate—lung cancer	6.28e-05	0.000258	CcSEcCtD
Quetiapine—Urinary tract disorder—Methotrexate—lung cancer	6.24e-05	0.000257	CcSEcCtD
Quetiapine—Photosensitivity reaction—Doxorubicin—lung cancer	6.24e-05	0.000257	CcSEcCtD
Quetiapine—Anaphylactic shock—Docetaxel—lung cancer	6.23e-05	0.000257	CcSEcCtD
Quetiapine—Weight increased—Doxorubicin—lung cancer	6.23e-05	0.000256	CcSEcCtD
Quetiapine—Pruritus—Gemcitabine—lung cancer	6.21e-05	0.000256	CcSEcCtD
Quetiapine—Urethral disorder—Methotrexate—lung cancer	6.2e-05	0.000255	CcSEcCtD
Quetiapine—Infection—Docetaxel—lung cancer	6.19e-05	0.000255	CcSEcCtD
Quetiapine—Weight decreased—Doxorubicin—lung cancer	6.19e-05	0.000255	CcSEcCtD
Quetiapine—Feeling abnormal—Etoposide—lung cancer	6.18e-05	0.000254	CcSEcCtD
Quetiapine—Hyperglycaemia—Doxorubicin—lung cancer	6.17e-05	0.000254	CcSEcCtD
Quetiapine—Diarrhoea—Irinotecan—lung cancer	6.17e-05	0.000254	CcSEcCtD
Quetiapine—Pneumonia—Doxorubicin—lung cancer	6.13e-05	0.000253	CcSEcCtD
Quetiapine—Gastrointestinal pain—Etoposide—lung cancer	6.13e-05	0.000252	CcSEcCtD
Quetiapine—Shock—Docetaxel—lung cancer	6.13e-05	0.000252	CcSEcCtD
Quetiapine—Nervous system disorder—Docetaxel—lung cancer	6.11e-05	0.000252	CcSEcCtD
Quetiapine—Thrombocytopenia—Docetaxel—lung cancer	6.1e-05	0.000251	CcSEcCtD
Quetiapine—Infestation NOS—Doxorubicin—lung cancer	6.1e-05	0.000251	CcSEcCtD
Quetiapine—Infestation—Doxorubicin—lung cancer	6.1e-05	0.000251	CcSEcCtD
Quetiapine—Visual impairment—Methotrexate—lung cancer	6.09e-05	0.000251	CcSEcCtD
Quetiapine—Tachycardia—Docetaxel—lung cancer	6.08e-05	0.00025	CcSEcCtD
Quetiapine—Feeling abnormal—Paclitaxel—lung cancer	6.06e-05	0.000249	CcSEcCtD
Quetiapine—Skin disorder—Docetaxel—lung cancer	6.05e-05	0.000249	CcSEcCtD
Quetiapine—Stevens-Johnson syndrome—Doxorubicin—lung cancer	6.05e-05	0.000249	CcSEcCtD
Quetiapine—Hypersensitivity—Cisplatin—lung cancer	6.03e-05	0.000248	CcSEcCtD
Quetiapine—Gastrointestinal pain—Paclitaxel—lung cancer	6.01e-05	0.000248	CcSEcCtD
Quetiapine—Diarrhoea—Gemcitabine—lung cancer	6.01e-05	0.000247	CcSEcCtD
Quetiapine—Erythema multiforme—Methotrexate—lung cancer	5.98e-05	0.000246	CcSEcCtD
Quetiapine—Dizziness—Irinotecan—lung cancer	5.96e-05	0.000245	CcSEcCtD
Quetiapine—Stomatitis—Doxorubicin—lung cancer	5.94e-05	0.000245	CcSEcCtD
Quetiapine—Jaundice—Doxorubicin—lung cancer	5.94e-05	0.000245	CcSEcCtD
Quetiapine—Anorexia—Docetaxel—lung cancer	5.94e-05	0.000245	CcSEcCtD
Quetiapine—Body temperature increased—Etoposide—lung cancer	5.93e-05	0.000244	CcSEcCtD
Quetiapine—Abdominal pain—Etoposide—lung cancer	5.93e-05	0.000244	CcSEcCtD
Quetiapine—Urinary tract infection—Doxorubicin—lung cancer	5.93e-05	0.000244	CcSEcCtD
Quetiapine—Conjunctivitis—Doxorubicin—lung cancer	5.93e-05	0.000244	CcSEcCtD
Quetiapine—Eye disorder—Methotrexate—lung cancer	5.91e-05	0.000243	CcSEcCtD
Quetiapine—Tinnitus—Methotrexate—lung cancer	5.9e-05	0.000243	CcSEcCtD
Quetiapine—Asthenia—Cisplatin—lung cancer	5.87e-05	0.000242	CcSEcCtD
Quetiapine—Cardiac disorder—Methotrexate—lung cancer	5.87e-05	0.000242	CcSEcCtD
Quetiapine—Sweating—Doxorubicin—lung cancer	5.85e-05	0.000241	CcSEcCtD
Quetiapine—Hypotension—Docetaxel—lung cancer	5.82e-05	0.00024	CcSEcCtD
Quetiapine—Abdominal pain—Paclitaxel—lung cancer	5.81e-05	0.000239	CcSEcCtD
Quetiapine—Body temperature increased—Paclitaxel—lung cancer	5.81e-05	0.000239	CcSEcCtD
Quetiapine—Hepatobiliary disease—Doxorubicin—lung cancer	5.77e-05	0.000237	CcSEcCtD
Quetiapine—Epistaxis—Doxorubicin—lung cancer	5.75e-05	0.000237	CcSEcCtD
Quetiapine—Angiopathy—Methotrexate—lung cancer	5.74e-05	0.000236	CcSEcCtD
Quetiapine—Vomiting—Irinotecan—lung cancer	5.73e-05	0.000236	CcSEcCtD
Quetiapine—Sinusitis—Doxorubicin—lung cancer	5.72e-05	0.000236	CcSEcCtD
Quetiapine—Immune system disorder—Methotrexate—lung cancer	5.71e-05	0.000235	CcSEcCtD
Quetiapine—Mediastinal disorder—Methotrexate—lung cancer	5.7e-05	0.000235	CcSEcCtD
Quetiapine—Agranulocytosis—Doxorubicin—lung cancer	5.69e-05	0.000234	CcSEcCtD
Quetiapine—Rash—Irinotecan—lung cancer	5.68e-05	0.000234	CcSEcCtD
Quetiapine—Dermatitis—Irinotecan—lung cancer	5.68e-05	0.000234	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Docetaxel—lung cancer	5.68e-05	0.000234	CcSEcCtD
Quetiapine—Chills—Methotrexate—lung cancer	5.67e-05	0.000234	CcSEcCtD
Quetiapine—Headache—Irinotecan—lung cancer	5.65e-05	0.000233	CcSEcCtD
Quetiapine—Insomnia—Docetaxel—lung cancer	5.64e-05	0.000232	CcSEcCtD
Quetiapine—Diarrhoea—Cisplatin—lung cancer	5.6e-05	0.000231	CcSEcCtD
Quetiapine—Paraesthesia—Docetaxel—lung cancer	5.6e-05	0.00023	CcSEcCtD
Quetiapine—Vomiting—Gemcitabine—lung cancer	5.58e-05	0.00023	CcSEcCtD
Quetiapine—Bradycardia—Doxorubicin—lung cancer	5.57e-05	0.000229	CcSEcCtD
Quetiapine—Dyspnoea—Docetaxel—lung cancer	5.56e-05	0.000229	CcSEcCtD
Quetiapine—Somnolence—Docetaxel—lung cancer	5.54e-05	0.000228	CcSEcCtD
Quetiapine—Mental disorder—Methotrexate—lung cancer	5.54e-05	0.000228	CcSEcCtD
Quetiapine—Rash—Gemcitabine—lung cancer	5.54e-05	0.000228	CcSEcCtD
Quetiapine—Dermatitis—Gemcitabine—lung cancer	5.53e-05	0.000228	CcSEcCtD
Quetiapine—Hypersensitivity—Etoposide—lung cancer	5.53e-05	0.000227	CcSEcCtD
Quetiapine—Malnutrition—Methotrexate—lung cancer	5.5e-05	0.000227	CcSEcCtD
Quetiapine—Haemoglobin—Doxorubicin—lung cancer	5.5e-05	0.000227	CcSEcCtD
Quetiapine—Headache—Gemcitabine—lung cancer	5.5e-05	0.000226	CcSEcCtD
Quetiapine—Rhinitis—Doxorubicin—lung cancer	5.49e-05	0.000226	CcSEcCtD
Quetiapine—Dyspepsia—Docetaxel—lung cancer	5.49e-05	0.000226	CcSEcCtD
Quetiapine—Clozapine—ABCB1—lung cancer	5.48e-05	0.0335	CrCbGaD
Quetiapine—Haemorrhage—Doxorubicin—lung cancer	5.48e-05	0.000225	CcSEcCtD
Quetiapine—Hepatitis—Doxorubicin—lung cancer	5.48e-05	0.000225	CcSEcCtD
Quetiapine—Hypoaesthesia—Doxorubicin—lung cancer	5.45e-05	0.000224	CcSEcCtD
Quetiapine—Pharyngitis—Doxorubicin—lung cancer	5.43e-05	0.000224	CcSEcCtD
Quetiapine—Decreased appetite—Docetaxel—lung cancer	5.42e-05	0.000223	CcSEcCtD
Quetiapine—Hypersensitivity—Paclitaxel—lung cancer	5.42e-05	0.000223	CcSEcCtD
Quetiapine—Urinary tract disorder—Doxorubicin—lung cancer	5.41e-05	0.000223	CcSEcCtD
Quetiapine—Oedema peripheral—Doxorubicin—lung cancer	5.39e-05	0.000222	CcSEcCtD
Quetiapine—Dysgeusia—Methotrexate—lung cancer	5.39e-05	0.000222	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Docetaxel—lung cancer	5.38e-05	0.000222	CcSEcCtD
Quetiapine—Asthenia—Etoposide—lung cancer	5.38e-05	0.000222	CcSEcCtD
Quetiapine—Connective tissue disorder—Doxorubicin—lung cancer	5.38e-05	0.000221	CcSEcCtD
Quetiapine—Fatigue—Docetaxel—lung cancer	5.37e-05	0.000221	CcSEcCtD
Quetiapine—Urethral disorder—Doxorubicin—lung cancer	5.37e-05	0.000221	CcSEcCtD
Quetiapine—Nausea—Irinotecan—lung cancer	5.36e-05	0.00022	CcSEcCtD
Quetiapine—Pain—Docetaxel—lung cancer	5.33e-05	0.000219	CcSEcCtD
Quetiapine—Constipation—Docetaxel—lung cancer	5.33e-05	0.000219	CcSEcCtD
Quetiapine—Back pain—Methotrexate—lung cancer	5.32e-05	0.000219	CcSEcCtD
Quetiapine—Pruritus—Etoposide—lung cancer	5.31e-05	0.000218	CcSEcCtD
Quetiapine—Visual impairment—Doxorubicin—lung cancer	5.28e-05	0.000217	CcSEcCtD
Quetiapine—Asthenia—Paclitaxel—lung cancer	5.28e-05	0.000217	CcSEcCtD
Quetiapine—Nausea—Gemcitabine—lung cancer	5.22e-05	0.000215	CcSEcCtD
Quetiapine—Vomiting—Cisplatin—lung cancer	5.2e-05	0.000214	CcSEcCtD
Quetiapine—Pruritus—Paclitaxel—lung cancer	5.2e-05	0.000214	CcSEcCtD
Quetiapine—Vision blurred—Methotrexate—lung cancer	5.19e-05	0.000214	CcSEcCtD
Quetiapine—Erythema multiforme—Doxorubicin—lung cancer	5.18e-05	0.000213	CcSEcCtD
Quetiapine—Rash—Cisplatin—lung cancer	5.16e-05	0.000212	CcSEcCtD
Quetiapine—Dermatitis—Cisplatin—lung cancer	5.16e-05	0.000212	CcSEcCtD
Quetiapine—Feeling abnormal—Docetaxel—lung cancer	5.14e-05	0.000211	CcSEcCtD
Quetiapine—Diarrhoea—Etoposide—lung cancer	5.13e-05	0.000211	CcSEcCtD
Quetiapine—Eye disorder—Doxorubicin—lung cancer	5.12e-05	0.000211	CcSEcCtD
Quetiapine—Ill-defined disorder—Methotrexate—lung cancer	5.11e-05	0.00021	CcSEcCtD
Quetiapine—Tinnitus—Doxorubicin—lung cancer	5.1e-05	0.00021	CcSEcCtD
Quetiapine—Gastrointestinal pain—Docetaxel—lung cancer	5.1e-05	0.00021	CcSEcCtD
Quetiapine—Anaemia—Methotrexate—lung cancer	5.09e-05	0.000209	CcSEcCtD
Quetiapine—Cardiac disorder—Doxorubicin—lung cancer	5.08e-05	0.000209	CcSEcCtD
Quetiapine—Diarrhoea—Paclitaxel—lung cancer	5.03e-05	0.000207	CcSEcCtD
Quetiapine—Angiopathy—Doxorubicin—lung cancer	4.97e-05	0.000204	CcSEcCtD
Quetiapine—Malaise—Methotrexate—lung cancer	4.96e-05	0.000204	CcSEcCtD
Quetiapine—Dizziness—Etoposide—lung cancer	4.96e-05	0.000204	CcSEcCtD
Quetiapine—Immune system disorder—Doxorubicin—lung cancer	4.95e-05	0.000204	CcSEcCtD
Quetiapine—Vertigo—Methotrexate—lung cancer	4.95e-05	0.000204	CcSEcCtD
Quetiapine—Mediastinal disorder—Doxorubicin—lung cancer	4.93e-05	0.000203	CcSEcCtD
Quetiapine—Body temperature increased—Docetaxel—lung cancer	4.93e-05	0.000203	CcSEcCtD
Quetiapine—Abdominal pain—Docetaxel—lung cancer	4.93e-05	0.000203	CcSEcCtD
Quetiapine—Leukopenia—Methotrexate—lung cancer	4.93e-05	0.000203	CcSEcCtD
Quetiapine—Chills—Doxorubicin—lung cancer	4.91e-05	0.000202	CcSEcCtD
Quetiapine—Dizziness—Paclitaxel—lung cancer	4.86e-05	0.0002	CcSEcCtD
Quetiapine—Nausea—Cisplatin—lung cancer	4.86e-05	0.0002	CcSEcCtD
Quetiapine—Cough—Methotrexate—lung cancer	4.8e-05	0.000198	CcSEcCtD
Quetiapine—Mental disorder—Doxorubicin—lung cancer	4.8e-05	0.000197	CcSEcCtD
Quetiapine—Convulsion—Methotrexate—lung cancer	4.77e-05	0.000196	CcSEcCtD
Quetiapine—Vomiting—Etoposide—lung cancer	4.77e-05	0.000196	CcSEcCtD
Quetiapine—Malnutrition—Doxorubicin—lung cancer	4.77e-05	0.000196	CcSEcCtD
Quetiapine—Rash—Etoposide—lung cancer	4.73e-05	0.000195	CcSEcCtD
Quetiapine—Dermatitis—Etoposide—lung cancer	4.72e-05	0.000194	CcSEcCtD
Quetiapine—Headache—Etoposide—lung cancer	4.7e-05	0.000193	CcSEcCtD
Quetiapine—Flatulence—Doxorubicin—lung cancer	4.7e-05	0.000193	CcSEcCtD
Quetiapine—Chest pain—Methotrexate—lung cancer	4.69e-05	0.000193	CcSEcCtD
Quetiapine—Arthralgia—Methotrexate—lung cancer	4.69e-05	0.000193	CcSEcCtD
Quetiapine—Myalgia—Methotrexate—lung cancer	4.69e-05	0.000193	CcSEcCtD
Quetiapine—Tension—Doxorubicin—lung cancer	4.68e-05	0.000193	CcSEcCtD
Quetiapine—Vomiting—Paclitaxel—lung cancer	4.68e-05	0.000192	CcSEcCtD
Quetiapine—Dysgeusia—Doxorubicin—lung cancer	4.67e-05	0.000192	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	4.65e-05	0.000192	CcSEcCtD
Quetiapine—Rash—Paclitaxel—lung cancer	4.64e-05	0.000191	CcSEcCtD
Quetiapine—Dermatitis—Paclitaxel—lung cancer	4.63e-05	0.000191	CcSEcCtD
Quetiapine—Discomfort—Methotrexate—lung cancer	4.63e-05	0.000191	CcSEcCtD
Quetiapine—Nervousness—Doxorubicin—lung cancer	4.63e-05	0.000191	CcSEcCtD
Quetiapine—Back pain—Doxorubicin—lung cancer	4.61e-05	0.00019	CcSEcCtD
Quetiapine—Headache—Paclitaxel—lung cancer	4.61e-05	0.00019	CcSEcCtD
Quetiapine—Hypersensitivity—Docetaxel—lung cancer	4.59e-05	0.000189	CcSEcCtD
Quetiapine—Muscle spasms—Doxorubicin—lung cancer	4.58e-05	0.000189	CcSEcCtD
Quetiapine—Confusional state—Methotrexate—lung cancer	4.53e-05	0.000186	CcSEcCtD
Quetiapine—Anaphylactic shock—Methotrexate—lung cancer	4.49e-05	0.000185	CcSEcCtD
Quetiapine—Vision blurred—Doxorubicin—lung cancer	4.49e-05	0.000185	CcSEcCtD
Quetiapine—Asthenia—Docetaxel—lung cancer	4.47e-05	0.000184	CcSEcCtD
Quetiapine—Infection—Methotrexate—lung cancer	4.46e-05	0.000184	CcSEcCtD
Quetiapine—Nausea—Etoposide—lung cancer	4.45e-05	0.000183	CcSEcCtD
Quetiapine—Ill-defined disorder—Doxorubicin—lung cancer	4.42e-05	0.000182	CcSEcCtD
Quetiapine—Pruritus—Docetaxel—lung cancer	4.41e-05	0.000182	CcSEcCtD
Quetiapine—Nervous system disorder—Methotrexate—lung cancer	4.41e-05	0.000181	CcSEcCtD
Quetiapine—Anaemia—Doxorubicin—lung cancer	4.41e-05	0.000181	CcSEcCtD
Quetiapine—Thrombocytopenia—Methotrexate—lung cancer	4.4e-05	0.000181	CcSEcCtD
Quetiapine—Agitation—Doxorubicin—lung cancer	4.38e-05	0.00018	CcSEcCtD
Quetiapine—Nausea—Paclitaxel—lung cancer	4.37e-05	0.00018	CcSEcCtD
Quetiapine—Skin disorder—Methotrexate—lung cancer	4.36e-05	0.00018	CcSEcCtD
Quetiapine—Hyperhidrosis—Methotrexate—lung cancer	4.34e-05	0.000179	CcSEcCtD
Quetiapine—Malaise—Doxorubicin—lung cancer	4.3e-05	0.000177	CcSEcCtD
Quetiapine—Vertigo—Doxorubicin—lung cancer	4.28e-05	0.000176	CcSEcCtD
Quetiapine—Anorexia—Methotrexate—lung cancer	4.28e-05	0.000176	CcSEcCtD
Quetiapine—Syncope—Doxorubicin—lung cancer	4.27e-05	0.000176	CcSEcCtD
Quetiapine—Leukopenia—Doxorubicin—lung cancer	4.27e-05	0.000176	CcSEcCtD
Quetiapine—Diarrhoea—Docetaxel—lung cancer	4.26e-05	0.000176	CcSEcCtD
Quetiapine—Palpitations—Doxorubicin—lung cancer	4.21e-05	0.000173	CcSEcCtD
Quetiapine—Hypotension—Methotrexate—lung cancer	4.2e-05	0.000173	CcSEcCtD
Quetiapine—Loss of consciousness—Doxorubicin—lung cancer	4.19e-05	0.000172	CcSEcCtD
Quetiapine—Cough—Doxorubicin—lung cancer	4.16e-05	0.000171	CcSEcCtD
Quetiapine—Convulsion—Doxorubicin—lung cancer	4.13e-05	0.00017	CcSEcCtD
Quetiapine—Dizziness—Docetaxel—lung cancer	4.12e-05	0.00017	CcSEcCtD
Quetiapine—Hypertension—Doxorubicin—lung cancer	4.11e-05	0.000169	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Methotrexate—lung cancer	4.09e-05	0.000168	CcSEcCtD
Quetiapine—Insomnia—Methotrexate—lung cancer	4.06e-05	0.000167	CcSEcCtD
Quetiapine—Chest pain—Doxorubicin—lung cancer	4.06e-05	0.000167	CcSEcCtD
Quetiapine—Arthralgia—Doxorubicin—lung cancer	4.06e-05	0.000167	CcSEcCtD
Quetiapine—Myalgia—Doxorubicin—lung cancer	4.06e-05	0.000167	CcSEcCtD
Quetiapine—Anxiety—Doxorubicin—lung cancer	4.04e-05	0.000166	CcSEcCtD
Quetiapine—Paraesthesia—Methotrexate—lung cancer	4.03e-05	0.000166	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	4.03e-05	0.000166	CcSEcCtD
Quetiapine—Discomfort—Doxorubicin—lung cancer	4.01e-05	0.000165	CcSEcCtD
Quetiapine—Dyspnoea—Methotrexate—lung cancer	4e-05	0.000165	CcSEcCtD
Quetiapine—Somnolence—Methotrexate—lung cancer	3.99e-05	0.000164	CcSEcCtD
Quetiapine—Dry mouth—Doxorubicin—lung cancer	3.97e-05	0.000163	CcSEcCtD
Quetiapine—Vomiting—Docetaxel—lung cancer	3.96e-05	0.000163	CcSEcCtD
Quetiapine—Dyspepsia—Methotrexate—lung cancer	3.95e-05	0.000163	CcSEcCtD
Quetiapine—Rash—Docetaxel—lung cancer	3.93e-05	0.000162	CcSEcCtD
Quetiapine—Dermatitis—Docetaxel—lung cancer	3.93e-05	0.000162	CcSEcCtD
Quetiapine—Confusional state—Doxorubicin—lung cancer	3.92e-05	0.000161	CcSEcCtD
Quetiapine—Decreased appetite—Methotrexate—lung cancer	3.91e-05	0.000161	CcSEcCtD
Quetiapine—Headache—Docetaxel—lung cancer	3.9e-05	0.000161	CcSEcCtD
Quetiapine—Anaphylactic shock—Doxorubicin—lung cancer	3.89e-05	0.00016	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Methotrexate—lung cancer	3.88e-05	0.00016	CcSEcCtD
Quetiapine—Fatigue—Methotrexate—lung cancer	3.87e-05	0.000159	CcSEcCtD
Quetiapine—Infection—Doxorubicin—lung cancer	3.86e-05	0.000159	CcSEcCtD
Quetiapine—Pain—Methotrexate—lung cancer	3.84e-05	0.000158	CcSEcCtD
Quetiapine—Shock—Doxorubicin—lung cancer	3.83e-05	0.000158	CcSEcCtD
Quetiapine—Nervous system disorder—Doxorubicin—lung cancer	3.81e-05	0.000157	CcSEcCtD
Quetiapine—Thrombocytopenia—Doxorubicin—lung cancer	3.81e-05	0.000157	CcSEcCtD
Quetiapine—Tachycardia—Doxorubicin—lung cancer	3.8e-05	0.000156	CcSEcCtD
Quetiapine—Skin disorder—Doxorubicin—lung cancer	3.78e-05	0.000156	CcSEcCtD
Quetiapine—Hyperhidrosis—Doxorubicin—lung cancer	3.76e-05	0.000155	CcSEcCtD
Quetiapine—Anorexia—Doxorubicin—lung cancer	3.71e-05	0.000153	CcSEcCtD
Quetiapine—Nausea—Docetaxel—lung cancer	3.7e-05	0.000152	CcSEcCtD
Quetiapine—Feeling abnormal—Methotrexate—lung cancer	3.7e-05	0.000152	CcSEcCtD
Quetiapine—Gastrointestinal pain—Methotrexate—lung cancer	3.67e-05	0.000151	CcSEcCtD
Quetiapine—Hypotension—Doxorubicin—lung cancer	3.63e-05	0.00015	CcSEcCtD
Quetiapine—Abdominal pain—Methotrexate—lung cancer	3.55e-05	0.000146	CcSEcCtD
Quetiapine—Body temperature increased—Methotrexate—lung cancer	3.55e-05	0.000146	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Doxorubicin—lung cancer	3.54e-05	0.000146	CcSEcCtD
Quetiapine—Insomnia—Doxorubicin—lung cancer	3.52e-05	0.000145	CcSEcCtD
Quetiapine—Paraesthesia—Doxorubicin—lung cancer	3.49e-05	0.000144	CcSEcCtD
Quetiapine—Dyspnoea—Doxorubicin—lung cancer	3.47e-05	0.000143	CcSEcCtD
Quetiapine—Somnolence—Doxorubicin—lung cancer	3.46e-05	0.000142	CcSEcCtD
Quetiapine—Dyspepsia—Doxorubicin—lung cancer	3.42e-05	0.000141	CcSEcCtD
Quetiapine—Decreased appetite—Doxorubicin—lung cancer	3.38e-05	0.000139	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Doxorubicin—lung cancer	3.36e-05	0.000138	CcSEcCtD
Quetiapine—Fatigue—Doxorubicin—lung cancer	3.35e-05	0.000138	CcSEcCtD
Quetiapine—Pain—Doxorubicin—lung cancer	3.33e-05	0.000137	CcSEcCtD
Quetiapine—Constipation—Doxorubicin—lung cancer	3.33e-05	0.000137	CcSEcCtD
Quetiapine—Hypersensitivity—Methotrexate—lung cancer	3.31e-05	0.000136	CcSEcCtD
Quetiapine—Asthenia—Methotrexate—lung cancer	3.22e-05	0.000133	CcSEcCtD
Quetiapine—Feeling abnormal—Doxorubicin—lung cancer	3.21e-05	0.000132	CcSEcCtD
Quetiapine—Gastrointestinal pain—Doxorubicin—lung cancer	3.18e-05	0.000131	CcSEcCtD
Quetiapine—Pruritus—Methotrexate—lung cancer	3.18e-05	0.000131	CcSEcCtD
Quetiapine—Body temperature increased—Doxorubicin—lung cancer	3.07e-05	0.000127	CcSEcCtD
Quetiapine—Abdominal pain—Doxorubicin—lung cancer	3.07e-05	0.000127	CcSEcCtD
Quetiapine—Diarrhoea—Methotrexate—lung cancer	3.07e-05	0.000127	CcSEcCtD
Quetiapine—Dizziness—Methotrexate—lung cancer	2.97e-05	0.000122	CcSEcCtD
Quetiapine—Hypersensitivity—Doxorubicin—lung cancer	2.87e-05	0.000118	CcSEcCtD
Quetiapine—Vomiting—Methotrexate—lung cancer	2.86e-05	0.000118	CcSEcCtD
Quetiapine—Rash—Methotrexate—lung cancer	2.83e-05	0.000117	CcSEcCtD
Quetiapine—Dermatitis—Methotrexate—lung cancer	2.83e-05	0.000116	CcSEcCtD
Quetiapine—Headache—Methotrexate—lung cancer	2.81e-05	0.000116	CcSEcCtD
Quetiapine—Asthenia—Doxorubicin—lung cancer	2.79e-05	0.000115	CcSEcCtD
Quetiapine—Pruritus—Doxorubicin—lung cancer	2.75e-05	0.000113	CcSEcCtD
Quetiapine—Nausea—Methotrexate—lung cancer	2.67e-05	0.00011	CcSEcCtD
Quetiapine—Diarrhoea—Doxorubicin—lung cancer	2.66e-05	0.00011	CcSEcCtD
Quetiapine—Dizziness—Doxorubicin—lung cancer	2.57e-05	0.000106	CcSEcCtD
Quetiapine—Vomiting—Doxorubicin—lung cancer	2.47e-05	0.000102	CcSEcCtD
Quetiapine—Rash—Doxorubicin—lung cancer	2.45e-05	0.000101	CcSEcCtD
Quetiapine—Dermatitis—Doxorubicin—lung cancer	2.45e-05	0.000101	CcSEcCtD
Quetiapine—Headache—Doxorubicin—lung cancer	2.44e-05	0.0001	CcSEcCtD
Quetiapine—Nausea—Doxorubicin—lung cancer	2.31e-05	9.51e-05	CcSEcCtD
Quetiapine—ADRA2A—GPCR downstream signaling—AKT1—lung cancer	2.31e-06	1.69e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—IL6—lung cancer	2.3e-06	1.69e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—HRAS—lung cancer	2.3e-06	1.69e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—IL6—lung cancer	2.3e-06	1.69e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—AKT1—lung cancer	2.3e-06	1.69e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—EGFR—lung cancer	2.3e-06	1.69e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—AKT1—lung cancer	2.3e-06	1.69e-05	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—PIK3CA—lung cancer	2.3e-06	1.69e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ABCB1—lung cancer	2.29e-06	1.68e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—AKT1—lung cancer	2.29e-06	1.68e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—IL6—lung cancer	2.29e-06	1.68e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—EP300—lung cancer	2.29e-06	1.68e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CASP3—lung cancer	2.28e-06	1.68e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—AKT1—lung cancer	2.28e-06	1.68e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IL2—lung cancer	2.28e-06	1.68e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—TP53—lung cancer	2.27e-06	1.67e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—HRAS—lung cancer	2.27e-06	1.67e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—IL6—lung cancer	2.27e-06	1.67e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MYC—lung cancer	2.27e-06	1.67e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—AKT1—lung cancer	2.26e-06	1.66e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MAPK3—lung cancer	2.26e-06	1.66e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MYC—lung cancer	2.26e-06	1.66e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—AKT1—lung cancer	2.25e-06	1.66e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—TYMS—lung cancer	2.25e-06	1.65e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—EP300—lung cancer	2.25e-06	1.65e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—EP300—lung cancer	2.24e-06	1.65e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—EP300—lung cancer	2.24e-06	1.65e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—PIK3CA—lung cancer	2.24e-06	1.65e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—IL6—lung cancer	2.24e-06	1.65e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—EP300—lung cancer	2.24e-06	1.64e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—EP300—lung cancer	2.23e-06	1.64e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—PIK3CA—lung cancer	2.23e-06	1.64e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GSTM1—lung cancer	2.22e-06	1.63e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CCND1—lung cancer	2.22e-06	1.63e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—SRC—lung cancer	2.22e-06	1.63e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MAPK3—lung cancer	2.22e-06	1.63e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3CD—lung cancer	2.22e-06	1.63e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—EGFR—lung cancer	2.22e-06	1.63e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—JUN—lung cancer	2.22e-06	1.63e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—PIK3CA—lung cancer	2.21e-06	1.62e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—PIK3CA—lung cancer	2.21e-06	1.62e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—EP300—lung cancer	2.21e-06	1.62e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—EGFR—lung cancer	2.21e-06	1.62e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—IL6—lung cancer	2.2e-06	1.62e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—EP300—lung cancer	2.2e-06	1.62e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MYC—lung cancer	2.2e-06	1.61e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—ALB—lung cancer	2.19e-06	1.61e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—SRC—lung cancer	2.19e-06	1.61e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—SRC—lung cancer	2.18e-06	1.6e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—SRC—lung cancer	2.18e-06	1.6e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—HRAS—lung cancer	2.17e-06	1.6e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—IL6—lung cancer	2.17e-06	1.6e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—KRAS—lung cancer	2.17e-06	1.6e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—SRC—lung cancer	2.17e-06	1.59e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—TP53—lung cancer	2.17e-06	1.59e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—VEGFA—lung cancer	2.17e-06	1.59e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MYC—lung cancer	2.16e-06	1.59e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MMP9—lung cancer	2.16e-06	1.59e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CDKN1A—lung cancer	2.15e-06	1.58e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—SRC—lung cancer	2.15e-06	1.58e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—EGFR—lung cancer	2.15e-06	1.58e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—PTEN—lung cancer	2.15e-06	1.58e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—STAT3—lung cancer	2.14e-06	1.58e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—SRC—lung cancer	2.14e-06	1.57e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—NRAS—lung cancer	2.14e-06	1.57e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—TP53—lung cancer	2.14e-06	1.57e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—TP53—lung cancer	2.14e-06	1.57e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—VEGFA—lung cancer	2.13e-06	1.57e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—VEGFA—lung cancer	2.13e-06	1.56e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—AKT1—lung cancer	2.13e-06	1.56e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—AKT1—lung cancer	2.12e-06	1.56e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—VEGFA—lung cancer	2.12e-06	1.56e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—EGFR—lung cancer	2.11e-06	1.55e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—VEGFA—lung cancer	2.11e-06	1.55e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—AKT1—lung cancer	2.11e-06	1.55e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—STAT3—lung cancer	2.11e-06	1.55e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CYP1A1—lung cancer	2.11e-06	1.55e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—STAT3—lung cancer	2.1e-06	1.55e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—NRAS—lung cancer	2.1e-06	1.55e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PIK3CB—lung cancer	2.1e-06	1.55e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—NRAS—lung cancer	2.1e-06	1.54e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—STAT3—lung cancer	2.1e-06	1.54e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—KRAS—lung cancer	2.1e-06	1.54e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—AKT1—lung cancer	2.09e-06	1.54e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—NRAS—lung cancer	2.09e-06	1.54e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—VEGFA—lung cancer	2.09e-06	1.54e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—STAT3—lung cancer	2.09e-06	1.54e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ERCC2—lung cancer	2.09e-06	1.54e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—NRAS—lung cancer	2.09e-06	1.53e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—VEGFA—lung cancer	2.09e-06	1.53e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—KRAS—lung cancer	2.09e-06	1.53e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTGS2—lung cancer	2.08e-06	1.53e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—IL6—lung cancer	2.08e-06	1.53e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—HRAS—lung cancer	2.07e-06	1.52e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—STAT3—lung cancer	2.07e-06	1.52e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—NRAS—lung cancer	2.07e-06	1.52e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—AKT1—lung cancer	2.07e-06	1.52e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—STAT3—lung cancer	2.07e-06	1.52e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—NRAS—lung cancer	2.06e-06	1.51e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PIK3CB—lung cancer	2.05e-06	1.51e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MAPK3—lung cancer	2.05e-06	1.51e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—EP300—lung cancer	2.05e-06	1.5e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—HRAS—lung cancer	2.04e-06	1.5e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—HRAS—lung cancer	2.04e-06	1.5e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTGS2—lung cancer	2.03e-06	1.5e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—AKT1—lung cancer	2.03e-06	1.49e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—KRAS—lung cancer	2.03e-06	1.49e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MAPK3—lung cancer	2.02e-06	1.48e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MAPK3—lung cancer	2.01e-06	1.48e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—AKT1—lung cancer	2.01e-06	1.47e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MAPK3—lung cancer	2e-06	1.47e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MAPK3—lung cancer	2e-06	1.47e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—KRAS—lung cancer	2e-06	1.47e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—PIK3CA—lung cancer	2e-06	1.47e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MYC—lung cancer	1.99e-06	1.46e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—SRC—lung cancer	1.99e-06	1.46e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—IL6—lung cancer	1.98e-06	1.46e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MAPK3—lung cancer	1.98e-06	1.45e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MAPK3—lung cancer	1.97e-06	1.45e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—PIK3CA—lung cancer	1.97e-06	1.45e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MYC—lung cancer	1.96e-06	1.44e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—IL6—lung cancer	1.96e-06	1.44e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—IL6—lung cancer	1.96e-06	1.44e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MYC—lung cancer	1.96e-06	1.44e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MYC—lung cancer	1.95e-06	1.43e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—EGFR—lung cancer	1.95e-06	1.43e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MYC—lung cancer	1.94e-06	1.43e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—VEGFA—lung cancer	1.94e-06	1.42e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3CB—lung cancer	1.94e-06	1.42e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TP53—lung cancer	1.93e-06	1.42e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—PIK3CA—lung cancer	1.93e-06	1.42e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MYC—lung cancer	1.92e-06	1.41e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—AKT1—lung cancer	1.92e-06	1.41e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MYC—lung cancer	1.92e-06	1.41e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—STAT3—lung cancer	1.92e-06	1.41e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTGS2—lung cancer	1.92e-06	1.41e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—EGFR—lung cancer	1.92e-06	1.41e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—PIK3CA—lung cancer	1.92e-06	1.41e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—NRAS—lung cancer	1.91e-06	1.41e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—EGFR—lung cancer	1.91e-06	1.41e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—EGFR—lung cancer	1.91e-06	1.4e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—EGFR—lung cancer	1.9e-06	1.4e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—EGFR—lung cancer	1.88e-06	1.38e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—EGFR—lung cancer	1.88e-06	1.38e-05	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—AKT1—lung cancer	1.87e-06	1.38e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—PIK3CA—lung cancer	1.86e-06	1.37e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TP53—lung cancer	1.86e-06	1.37e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TP53—lung cancer	1.85e-06	1.36e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—HRAS—lung cancer	1.85e-06	1.36e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—KRAS—lung cancer	1.84e-06	1.35e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—PIK3CA—lung cancer	1.83e-06	1.35e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MAPK3—lung cancer	1.83e-06	1.35e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—AKT1—lung cancer	1.83e-06	1.35e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—AKT1—lung cancer	1.82e-06	1.34e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTEN—lung cancer	1.82e-06	1.34e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—KRAS—lung cancer	1.81e-06	1.33e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—PIK3CA—lung cancer	1.81e-06	1.33e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—APOA1—lung cancer	1.81e-06	1.33e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—KRAS—lung cancer	1.81e-06	1.33e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—AKT1—lung cancer	1.81e-06	1.33e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—AKT1—lung cancer	1.81e-06	1.33e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TP53—lung cancer	1.8e-06	1.33e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—KRAS—lung cancer	1.8e-06	1.32e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—KRAS—lung cancer	1.8e-06	1.32e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MYC—lung cancer	1.78e-06	1.31e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—HRAS—lung cancer	1.78e-06	1.31e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—KRAS—lung cancer	1.78e-06	1.31e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTEN—lung cancer	1.77e-06	1.3e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TP53—lung cancer	1.77e-06	1.3e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—KRAS—lung cancer	1.77e-06	1.3e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—HRAS—lung cancer	1.77e-06	1.3e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—IL6—lung cancer	1.77e-06	1.3e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—EGFR—lung cancer	1.74e-06	1.28e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—EP300—lung cancer	1.73e-06	1.27e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—HRAS—lung cancer	1.72e-06	1.27e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—IL6—lung cancer	1.71e-06	1.25e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—HRAS—lung cancer	1.7e-06	1.25e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—IL6—lung cancer	1.7e-06	1.25e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—EP300—lung cancer	1.69e-06	1.24e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—PIK3CA—lung cancer	1.69e-06	1.24e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTEN—lung cancer	1.67e-06	1.23e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—PIK3CA—lung cancer	1.66e-06	1.22e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—PIK3CA—lung cancer	1.66e-06	1.22e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PIK3CA—lung cancer	1.66e-06	1.22e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—PIK3CA—lung cancer	1.66e-06	1.22e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CG—lung cancer	1.65e-06	1.21e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—IL6—lung cancer	1.65e-06	1.21e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—PIK3CA—lung cancer	1.65e-06	1.21e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—KRAS—lung cancer	1.65e-06	1.21e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TP53—lung cancer	1.64e-06	1.2e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—PIK3CA—lung cancer	1.63e-06	1.2e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—AKT1—lung cancer	1.63e-06	1.2e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—PIK3CA—lung cancer	1.63e-06	1.2e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—IL6—lung cancer	1.62e-06	1.19e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—AKT1—lung cancer	1.61e-06	1.18e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TP53—lung cancer	1.61e-06	1.18e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TP53—lung cancer	1.61e-06	1.18e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TP53—lung cancer	1.6e-06	1.18e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TP53—lung cancer	1.6e-06	1.17e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—EP300—lung cancer	1.59e-06	1.17e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TP53—lung cancer	1.58e-06	1.16e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TP53—lung cancer	1.58e-06	1.16e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—AKT1—lung cancer	1.57e-06	1.16e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—POMC—lung cancer	1.57e-06	1.16e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—AKT1—lung cancer	1.57e-06	1.15e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—HRAS—lung cancer	1.56e-06	1.15e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—HRAS—lung cancer	1.54e-06	1.13e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—HRAS—lung cancer	1.54e-06	1.13e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—HRAS—lung cancer	1.53e-06	1.13e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CREBBP—lung cancer	1.53e-06	1.13e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—HRAS—lung cancer	1.53e-06	1.12e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—AKT1—lung cancer	1.52e-06	1.12e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—PIK3CA—lung cancer	1.51e-06	1.11e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—HRAS—lung cancer	1.51e-06	1.11e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—HRAS—lung cancer	1.51e-06	1.11e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—AKT1—lung cancer	1.5e-06	1.1e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—IL6—lung cancer	1.5e-06	1.1e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—AKT1—lung cancer	1.48e-06	1.09e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—IL6—lung cancer	1.47e-06	1.08e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—IL6—lung cancer	1.47e-06	1.08e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—IL6—lung cancer	1.47e-06	1.08e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TP53—lung cancer	1.46e-06	1.08e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—IL6—lung cancer	1.46e-06	1.07e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CD—lung cancer	1.45e-06	1.07e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—IL6—lung cancer	1.45e-06	1.06e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—IL6—lung cancer	1.44e-06	1.06e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ALB—lung cancer	1.43e-06	1.05e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—HRAS—lung cancer	1.4e-06	1.03e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—AKT1—lung cancer	1.38e-06	1.02e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—AKT1—lung cancer	1.36e-06	9.99e-06	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—AKT1—lung cancer	1.36e-06	9.97e-06	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—AKT1—lung cancer	1.36e-06	9.96e-06	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—AKT1—lung cancer	1.35e-06	9.94e-06	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—AKT1—lung cancer	1.35e-06	9.91e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IL6—lung cancer	1.34e-06	9.86e-06	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—AKT1—lung cancer	1.33e-06	9.81e-06	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—AKT1—lung cancer	1.33e-06	9.79e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PIK3CA—lung cancer	1.28e-06	9.43e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CB—lung cancer	1.27e-06	9.3e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTGS2—lung cancer	1.25e-06	9.22e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PIK3CA—lung cancer	1.25e-06	9.2e-06	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—AKT1—lung cancer	1.24e-06	9.09e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3CA—lung cancer	1.18e-06	8.67e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTEN—lung cancer	1.09e-06	8.04e-06	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—AKT1—lung cancer	1.05e-06	7.7e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—EP300—lung cancer	1.04e-06	7.67e-06	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—AKT1—lung cancer	1.02e-06	7.52e-06	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—AKT1—lung cancer	9.64e-07	7.09e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CA—lung cancer	7.71e-07	5.67e-06	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—AKT1—lung cancer	6.3e-07	4.63e-06	CbGpPWpGaD
